E-LIB Suche - Ergebnisse für: DORIVAL, C

1

Sustained virological response to Do hepatitis C DAA treatm..:

Carrieri, P ; Carrat, F ; Delarocque-Astagneau, E...
European Journal of Public Health. 29 (2019) Supplement_4 - p. , 2019

Link: https://doi.org/10.1093/..

2

Letter: more studies are needed to elucidate the impact of ..:

Pol, S. ; Haour, G. ; Fontaine, H....
Alimentary Pharmacology & Therapeutics. 47 (2018) 4 - p. 543-544 , 2018

Link: https://doi.org/10.1111/..

3

Effect of resistance-associated substitutions on retreatmen..:

Chevaliez, S. ; Trimoulet, P. ; Dorival, C....
Journal of Hepatology. 66 (2017) 1 - p. S84 , 2017

Link: https://doi.org/10.1016/..

4

INTERFERON‐FREE ANTIVIRAL TREATMENT IN B‐CELL LYMPHOPROLIFE..:

Frigeni, M. ; Visco, C. ; Besson, C....
Hematological Oncology. 35 (2017) S2 - p. 145-146 , 2017

Link: https://doi.org/10.1002/..

5

The negative impact of HBV/HCV coinfection on cirrhosis and..:

Pol, S. ; Haour, G. ; Fontaine, H....
Alimentary Pharmacology & Therapeutics. 46 (2017) 11-12 - p. 1054-1060 , 2017

Link: https://doi.org/10.1111/..

6

P0794 : Relationship between HCV genotype, liver co-morbidi..:

Carrat, F. ; Haour, G. ; Fontaine, H....
Journal of Hepatology. 62 (2015) - p. S630-S631 , 2015

Link: https://doi.org/10.1016/..

7

P0795 : Safety and efficacy of sofosbuvir-containing regime..:

De Ledinghen, V. ; Fontaine, H. ; Dorival, C....
Journal of Hepatology. 62 (2015) - p. S631-S632 , 2015

Link: https://doi.org/10.1016/..

8

P0468 : Negative impact of HBV/HCV coinfection on HBV or HC..:

Pol, S. ; Lucier, S. ; Fontaine, H....
Journal of Hepatology. 62 (2015) - p. S488-S489 , 2015

Link: https://doi.org/10.1016/..

9

A Model‐Based Illustrative Exploratory Approach to Optimize..:

Laouénan, C ; Guedj, J ; Peytavin, G...
CPT: Pharmacometrics & Systems Pharmacology. 4 (2014) 1 - p. 37-40 , 2014

Link: https://doi.org/10.1002/..

10

60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAP..:

Fontaine, H. ; Hezode, C. ; Dorival, C....
Journal of Hepatology. 58 (2013) - p. S27 , 2013

Link: https://doi.org/10.1016/..

11

8 SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PE..:

Hezode, C. ; Dorival, C. ; Zoulim, F....
Journal of Hepatology. 56 (2012) - p. S4 , 2012

Link: https://doi.org/10.1016/..

12

Long-lasting Symptoms After an Acute COVID-19 Infection and..:

Robineau, Olivier ; Zins, M ; Touvier, M...
10.1001/jamanetworkopen.2022.40985. , 2023

Link: https://hdl.handle.net/2..

13

Publisher Correction: Heterogeneous SARS-CoV-2 humoral resp..:

Carrat, F ; Villarroel, PMS ; Lapidus, N...
issn:2045-2322. , 2022

Link: http://hdl.handle.net/11..

14

Heterogeneous SARS-CoV-2 humoral response after COVID-19 va..:

Carrat, F ; Villarroel, PMS ; Lapidus, N...
issn:2045-2322. , 2022

Link: http://hdl.handle.net/11..

15

Clinical outcomes in patients with chronic hepatitis C afte..:

CARRAT, F ; FONTAINE, H ; DORIVAL, C...
0140-6736. , 2019

Link: https://oskar-bordeaux.f..